- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07615244
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
Přehled studie
Postavení
Intervence / Léčba
- Diagnostický test: Factor VIII (FVIII)
- Diagnostický test: Von Willebrand factor (VWF) antigen
- Diagnostický test: VWF:RCo
- Diagnostický test: VWF-propeptide
- Diagnostický test: VWF multimers
- Diagnostický test: sP-selectin
- Diagnostický test: sCD40L
- Diagnostický test: F1+2
- Diagnostický test: VEGF-A
- Diagnostický test: VCAM
- Diagnostický test: ICAM
- Diagnostický test: IL-1β
- Diagnostický test: IL-6
- Diagnostický test: PTX3
- Diagnostický test: BlyS
- Diagnostický test: Neutrophil elastase and myeloperoxidase (NETs) markers
- Diagnostický test: soluble C5b-9
- Diagnostický test: C5a
- Diagnostický test: NFL
- Diagnostický test: GFAP
- Genetický: Whole exome sequencing - WES
- Diagnostický test: Proteomic Analysis
- Diagnostický test: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- Diagnostický test: Microfluidic Flow Chamber
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Milano
-
Milan, Milano, Itálie, 20122
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- aged ≥18 years
- with a confirmed diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) in acute phase of a first or recurrent episode (cohort 1) or referred at our outpatient clinic (S.C. Medicina - Emostasi e Trombosi) during clinical remission at more than 3 months from the clinical response of the previous episode (cohort 2). In any case, patient enrolment will always take place in the S.C. Medicina - Emostasi e Trombosi
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria or have known contraindications to the instrumental exam included in the study (MRI).
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Diagnostický
- Přidělení: Nerandomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Jiný: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
Jiný: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Prevalence
Časové okno: From enrollment to the last visit (after 36 months from T0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from T0)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Cerebral microcirculation lesions
Časové okno: From enrollment to the last visit (after 36 months from T0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from T0)
|
|
Retinal microcirculation changes
Časové okno: From enrollment to the last visit (after 36 months from T0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from T0)
|
|
Peripheral microcirculation
Časové okno: From enrollment to the last visit (after 36 months from T0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from T0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
Časové okno: From enrollment to the last visit (36 months from T0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from T0)
|
|
Modification of preclinical biomarkers
Časové okno: From enrollment to the last visit (36 months from T0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from T0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
Časové okno: From enrollment to the last visit (36 months from T0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from T0)
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Cytopenie
- Patologické procesy
- Krvácení
- Kožní projevy
- Hematologická onemocnění
- Poruchy srážení krve
- Poruchy krevních destiček
- Trombotické mikroangiopatie
- Purpura, trombocytopenická
- Purpura
- Trombocytopenie
- Trombofilie
- Patologické stavy, příznaky a symptomy
- Příznaky a symptomy
- Hemická a lymfatická onemocnění
- Purpura, trombotická trombocytopenická
- Vyšetřovací techniky
- Genetické techniky
- Sekvenční analýza
- Sekvenční analýza, DNA
- Sekvenování celého genomu
- Exome sekvenování
Další identifikační čísla studie
- IRCCSMaggioreH (IRCCSMaggioreH)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Factor VIII (FVIII)
-
BayerDokončenoHemofilie A | Hemofilie BJižní Afrika, Polsko, Spojené království
-
Novo Nordisk A/SDokončenoVrozená porucha krvácení | Vrozený nedostatek FVIISlovensko, Izrael, Španělsko, Indie, Írán, Islámská republika, Pákistán, Krocan, Německo, Srbsko, Itálie, Řecko, Thajsko, Francie, Spojené státy, Hongkong, Venezuela
-
Sygehus LillebaeltCeraPedics, IncNeznámý
-
University of California, San FranciscoDokončenoHIV infekce | Sarkom, KaposiSpojené státy
-
Spine Centre of Southern DenmarkCeraPedics, Inc; OrtotechDokončenoBolesti v kříži | Spinální stenózaDánsko
-
Louisiana State University Health Sciences Center...Neznámý
-
Novo Nordisk A/SDokončenoJiná porucha hemostázy | Hemoragická cystitidaSpojené státy
-
Novo Nordisk A/SUkončenoZískaná porucha krvácení | Kardiochirurgická operace vyžadující kardiopulmonální bypassSpojené státy, Španělsko, Německo, Švédsko, Spojené království, Argentina, Itálie, Brazílie, Dánsko, Francie, Indie, Malajsie, Singapur, Jižní Afrika
-
Novo Nordisk A/SDokončenoVrozená porucha krvácení | Hemofilie A s inhibitory | Hemofilie B s inhibitoryFrancie, Spojené království, Španělsko, Izrael, Polsko, Krocan, Maďarsko
-
Wuhan UniversityZatím nenabíráme